Patents by Inventor Peter Meldgaard

Peter Meldgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR blood monitoring
    Patent number: 9914975
    Abstract: Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: March 13, 2018
    Assignees: Roche Molecular Systems, Inc., Aarhus University
    Inventors: Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • Mutation testing
    Patent number: 9873913
    Abstract: Improved methods of assessing status of a solid tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: January 23, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Barbara Klughammer, Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • EGFR BLOOD MONITORING
    Publication number: 20160237507
    Abstract: Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Application
    Filed: April 13, 2016
    Publication date: August 18, 2016
    Inventors: Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • EGFR Blood Monitoring
    Publication number: 20140287417
    Abstract: Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 25, 2014
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • EGFR Mutation Blood Testing
    Publication number: 20140272953
    Abstract: Improved methods of assessing status of a solid tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 18, 2014
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Barbara Klughammer, Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu